Finding new treatments for TPI deficiency in children
High-content screening for TPI Deficiency therapeutics
This study is looking for new treatments for TPI deficiency, a serious condition in kids that can cause health problems like anemia and brain damage, by testing different compounds to see if they can help stabilize a faulty protein and improve health outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10888362 on NIH RePORTER |
What this research studies
This research focuses on TPI deficiency, a severe childhood metabolic disorder that leads to serious health issues like anemia and brain damage. The team has developed a human cellular model to study a common mutation associated with this condition and is using high-content screening to identify potential therapeutic compounds from a large library. By testing these compounds, they aim to find new small molecule therapies that can stabilize the mutant TPI protein and improve patient outcomes. The research includes validating these compounds in both laboratory and animal models to ensure their effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with TPI deficiency or those who exhibit symptoms related to this condition.
Not a fit: Patients with TPI deficiency caused by mutations that do not affect the protein's stability or function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments for TPI deficiency, significantly improving the quality of life for affected children.
How similar studies have performed: While the approach of using high-content screening for TPI deficiency is innovative, similar methodologies have shown promise in identifying treatments for other metabolic disorders.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Palladino, Michael John — University of Pittsburgh at Pittsburgh
- Study coordinator: Palladino, Michael John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.